Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXTP7I
|
||||
| Drug Name |
N3-(2-methoxy-5-morpholinophenyl)-1-(pyridin-2-yl)-1H-1,2,4-triazole-3,5-diamine
|
||||
| Synonyms |
CHEMBL1833992
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C18H21N7O2
|
||||
| Canonical SMILES |
COc1ccc(cc1Nc2nc(N)n(n2)c3ccccn3)N4CCOCC4
|
||||
| InChI |
InChI=1S/C18H21N7O2/c1-26-15-6-5-13(24-8-10-27-11-9-24)12-14(15)21-18-22-17(19)25(23-18)16-4-2-3-7-20-16/h2-7,12H,8-11H2,1H3,(H3,19,21,22,23)
|
||||
| InChIKey |
WPFRNEQAKJNVPZ-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | FL cytokine receptor | Target Info | [1587926] | ||
| Mast/stem cell growth factor receptor | Target Info | [1587926] | |||
| KEGG Pathway | Cytokine-cytokine receptor interaction | ||||
| Hematopoietic cell lineage | |||||
| Pathways in cancer | |||||
| Transcriptional misregulation in cancer | |||||
| Acute myeloid leukemia | |||||
| Central carbon metabolism in cancerhsa04014:Ras signaling pathway | |||||
| Rap1 signaling pathway | |||||
| Endocytosis | |||||
| PI3K-Akt signaling pathway | |||||
| Melanogenesis | |||||
| Central carbon metabolism in cancer | |||||
| Pathway Interaction Database | C-MYB transcription factor network | ||||
| Signaling events mediated by Stem cell factor receptor (c-Kit) | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.